BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Larsen FS, Vainer B, Eefsen M, Bjerring PN, Hansen BA. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol 2007; 13(23): 3232-3236 [PMID: 17589903 DOI: 10.3748/wjg.v13.i23.3232]
URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3232.htm
(0) (0) (5421) (96)
Number Citing Articles
1
A. M. C. Baven‐Pronk, M. J. Coenraad, H. R. van Buuren, R. A. de Man, K. J. van Erpecum, M. M. H. Lamers, J. P. H. Drenth, A. P. van den Berg, U. H. Beuers, J. den Ouden, G. H. Koek, C. M. J. van Nieuwkerk, G. Bouma, J. T. Brouwer, B. van Hoek. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Alimentary Pharmacology & Therapeutics 2011; 34(3) doi: 10.1111/j.1365-2036.2011.04727.x
2
Albert J Czaja, Yusuf Bayraktar. Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World Journal of Gastroenterology 2009; 15(19): 2314-2328 doi: 10.3748/wjg.15.2314
3
Chih-Wei Chiu, Kuo-Ting Sun, Shih-Ting Huang, I-Kuan Wang, Chi-Yuan Li, Tung-Min Yu. The Effect of Anti-Viral Treatment of HCV Infection on Outcomes of Renal Transplant Patients with Chronic HCV Infection: A Real-World Cohort Study. Biomedicines 2025; 13(11) doi: 10.3390/biomedicines13112842
4
V.M. Navas López, J. Blasco Alonso, C. Sierra Salinas, A. Barco Gálvez, M.I. Vicioso Recio. Eficacia y seguridad de tacrolimus oral para el tratamiento de la enfermedad inflamatoria intestinal pediátrica. Anales de Pediatría 2009; 70(6) doi: 10.1016/j.anpedi.2009.03.005
5
Andréanne N. Zizzo, Pamela L. Valentino, Prakesh S. Shah, Binita M. Kamath. Second‐line Agents in Pediatric Patients With Autoimmune Hepatitis. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(1) doi: 10.1097/MPG.0000000000001530
6
C R Grant, B S Holder, R Liberal, M A Heneghan, Y Ma, G Mieli-Vergani, D Vergani, M S Longhi. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. Clinical and Experimental Immunology 2017; 189(1) doi: 10.1111/cei.12956
7
Kenneth R Snider, Teresa G Potter. Budesonide for the Treatment of Autoimmune Hepatitis. Annals of Pharmacotherapy 2011; 45(9) doi: 10.1345/aph.1Q244
8
Albert J Czaja. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut and Liver 2016; 10(2) doi: 10.5009/gnl15352
9
Andrew D. Yeoman, Rachel H. Westbrook, Yoh Zen, Paola Maninchedda, Bernard C. Portmann, John Devlin, John G. O'Grady, Phillip M. Harrison, Michael A. Heneghan. Early Predictors of Corticosteroid Treatment Failure in Icteric Presentations of Autoimmune Hepatitis Δ. Hepatology 2011; 53(3) doi: 10.1002/hep.24141
10
Hind I. Fallatah, Hisham O. Akbar. Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview. Autoimmune Diseases 2012; 2012 doi: 10.1155/2012/312817
11
Marta Casal Moura, Rodrigo Liberal, Hélder Cardoso, Ana Maria Horta e Vale, Guilherme Macedo. Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids. World Journal of Hepatology 2014; 6(6): 410-418 doi: 10.4254/wjh.v6.i6.410
12
Dermot Gleeson, Rosemary Bornand, Ann Brownlee, Harpreet Dhaliwal, Jessica K Dyson, Janeane Hails, Paul Henderson, Deirdre Kelly, George F Mells, Rosa Miquel, Ye H Oo, Anthea Sutton, Andrew Yeoman, Michael A Heneghan. British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis. Gut 2025; 74(9) doi: 10.1136/gutjnl-2024-333171
13
M. M. Tannous, J. Cheng, K. Muniyappa, I. Farooq, A. Bharara, M. Kappus, V. Luketic, R. T. Stravtiz, M. Fuchs, P. Puri, A. Sanyal, R. Sterling. Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience. Alimentary Pharmacology & Therapeutics 2011; 34(3) doi: 10.1111/j.1365-2036.2011.04749.x
14
Rodrigo Liberal, Edward L. Krawitt, John M. Vierling, Michael P. Manns, Giorgina Mieli-Vergani, Diego Vergani. Cutting edge issues in autoimmune hepatitis. Journal of Autoimmunity 2016; 75 doi: 10.1016/j.jaut.2016.07.005
15
Albert J. Czaja. Evolving paradigm of treatment for autoimmune hepatitis. Expert Review of Clinical Immunology 2017; 13(8) doi: 10.1080/1744666X.2017.1319764
16
Qi-Xia Wang, Li Yan, Xiong Ma. Autoimmune Hepatitis in the Asia-Pacific Area. Journal of Clinical and Translational Hepatology 2018; 6(1) doi: 10.14218/JCTH.2017.00032
17
Claudia S Bovensiepen, Miriam Schakat, Marcial Sebode, Roman Zenouzi, Johannes Hartl, Moritz Peiseler, Jun Li, Lara Henze, Anna Woestemeier, Christoph Schramm, Ansgar W Lohse, Johannes Herkel, Christina Weiler-Normann. TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis. The Journal of Immunology 2019; 203(12) doi: 10.4049/jimmunol.1900124
18
A. D. YEOMAN, M. S. LONGHI, M. A. HENEGHAN. Review article: the modern management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2010; 31(8) doi: 10.1111/j.1365-2036.2010.04241.x
19
R. Liberal, Y. S. de Boer, R. J. Andrade, G. Bouma, G. N. Dalekos, A. Floreani, D. Gleeson, G. M. Hirschfield, P. Invernizzi, M. Lenzi, A. W. Lohse, G. Macedo, P. Milkiewicz, B. Terziroli, B. van Hoek, J. M. Vierling, M. A. Heneghan. Expert clinical management of autoimmune hepatitis in the real world. Alimentary Pharmacology & Therapeutics 2017; 45(5) doi: 10.1111/apt.13907
20
Joanna Ramirez Marlaka, Nikos Papadogiannakis, Björn Fischler, Thomas H. Casswall, Eva Beijer, Antal Németh. Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis. Acta Paediatrica 2012; 101(9) doi: 10.1111/j.1651-2227.2012.02745.x
21
Rinaldo Pellicano, Arianna Ferro, Francesca Cicerchia, Simone Mattivi, Sharmila Fagoonee, Marilena Durazzo. Autoimmune Hepatitis and Fibrosis. Journal of Clinical Medicine 2023; 12(5) doi: 10.3390/jcm12051979
22
Albert J Czaja. Drug choices in autoimmune hepatitis: Part B – nonsteroids. Expert Review of Gastroenterology & Hepatology 2012; 6(5) doi: 10.1586/egh.12.38
23
Jérôme Dumortier, Carlos Torres Arita, Christine Rivet, Catherine LeGall, Raymonde Bouvier, Nicole Fabien, Olivier Guillaud, Sophie Collardeau-Frachon, Jean-Yves Scoazec, Alain Lachaux. Long-term treatment reduction and steroids withdrawal in children with autoimmune hepatitis: a single centre experience on 55 children. European Journal of Gastroenterology & Hepatology 2009; 21(12) doi: 10.1097/MEG.0b013e32832ad5f7
24
Ignasi Olivas, Sergio Rodríguez-Tajes, Maria Carlota Londoño. Hepatitis autoinmune: retos y novedades. Medicina Clínica 2022; 159(6) doi: 10.1016/j.medcli.2022.04.004
25
Stuart K. Roberts, Simone I. Strasser, Amanda J. Nicoll, William Kemp, Ammar Majeed, Joanne Mitchell, Katherine Stuart, Paul Gow, Siddharth Sood, Gerry MacQuillan, Jacob George, Jonathan Mitchell, Geoffrey W. McCaughan. Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis. Scandinavian Journal of Gastroenterology 2020; 55(11) doi: 10.1080/00365521.2020.1821764
26
Jonah N. Rubin, Helen S. Te. Refractory Autoimmune Hepatitis: Beyond Standard Therapy. Digestive Diseases and Sciences 2016; 61(6) doi: 10.1007/s10620-015-4022-0
27
Albert J. Czaja, Michael P. Manns. Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology 2010; 139(1) doi: 10.1053/j.gastro.2010.04.053
28
Palak J. Trivedi, Gideon M. Hirschfield. Treatment of autoimmune liver disease: current and future therapeutic options. Therapeutic Advances in Chronic Disease 2013; 4(3) doi: 10.1177/2040622313478646
29
Diego Vergani, Giorgina Mieli-Vergani. Pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2011; 12(4) doi: 10.1517/14656566.2011.524206
30
Annarosa Floreani, Rodrigo Liberal, Diego Vergani, Giorgina Mieli-Vergani. Autoimmune hepatitis: Contrasts and comparisons in children and adults – A comprehensive review. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.08.004
31
Nora V. Bergasa. Clinical Cases in Hepatology. 2022;  doi: 10.1007/978-1-4471-4715-2_4
32
Ellina Lytvyak, Devika Shreekumar, Yu Jun Wong and Aldo J. Montano-Loza. Updates in Autoimmune Diseases [Working Title]. 2026;  doi: 10.5772/intechopen.1013551
33
V.M. Navas-López, J. Blasco Alonso, M.J. Serrano Nieto, F. Girón Fernández-Crehuet, M.D. Argos Rodriguez, C. Sierra Salinas. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis. Journal of Crohn's and Colitis 2014; 8(1) doi: 10.1016/j.crohns.2013.03.006
34
Stephen Kriese, Michael A Heneghan. Current concepts in the diagnosis and management of autoimmune hepatitis. Frontline Gastroenterology 2013; 4(1) doi: 10.1136/flgastro-2012-100208
35
Rodrigo Liberal, Ynto S de Boer, Michael A Heneghan. Established and novel therapeutic options for autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 2021; 6(4) doi: 10.1016/S2468-1253(20)30328-9
36
Binod Kumar, Akshaya Ramachandran, Gulam Waris. Hepatitis C - From Infection to Cure. 2018;  doi: 10.5772/intechopen.75916
37
Aldo J. Montano-Loza. Autoimmune Hepatitis. 2012;  doi: 10.1007/978-1-60761-569-9_6
38
Shuhao Yu, Zhizhong Guo, Yan Guan, Yi-Yu Lu, Pei Hao, Yixue Li, Shi-Bing Su. Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae. Evidence-Based Complementary and Alternative Medicine 2012; 2012 doi: 10.1155/2012/986427
39
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6) doi: 10.1586/egh.09.53
40
Shiv K. Sarin, Ashok Choudhury. Acute-on-chronic liver failure: terminology, mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2016; 13(3) doi: 10.1038/nrgastro.2015.219
41
Carlos Ferre-Aracil, Mar Riveiro-Barciela, María Trapero-Marugán, Manuel Rodríguez-Perálvarez, Laura-Patricia Llovet, Luis Téllez, Yolanda Sánchez-Torrijos, Fernando Díaz-Fontenla, Magdalena Salcedo-Plaza, Patricia Álvarez-López, Manuel de la Mata, María-Carlota Londoño, Rafael Bañares-Cañizares, José Luis Calleja. Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study. Digestive Diseases and Sciences 2021; 66(8) doi: 10.1007/s10620-020-06569-9
42
Dinesh Jothimani, Matthew E Cramp, Jonathon D Mitchell, Tim J S Cross. Treatment of autoimmune hepatitis: A review of current and evolving therapies. Journal of Gastroenterology and Hepatology 2011; 26(4) doi: 10.1111/j.1440-1746.2010.06579.x
43
Luigi Muratori, Maria Serena Longhi. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.06.016
44
Cumali Efe, Haider Al Taii, Henriette Ytting, Niklas Aehling, Rahima A. Bhanji, Hannes Hagström, Tugrul Purnak, Luigi Muratori, Mårten Werner, Paolo Muratori, Daniel Klintman, Thomas D. Schiano, Aldo J. Montano-Loza, Thomas Berg, Fin Stolze Larsen, Naim Alkhouri, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida, Staffan Wahlin. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences 2018; 63(5) doi: 10.1007/s10620-018-5011-x
45
Mohamad Hanouneh, Michael M. Ritchie, Mona Ascha, Mustafa S. Ascha, Alice Chedid, Anawin Sanguankeo, Nizar N. Zein, Ibrahim A. Hanouneh. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis. Scandinavian Journal of Gastroenterology 2019; 54(1) doi: 10.1080/00365521.2018.1551498
46
Albert J Czaja. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Review of Gastroenterology & Hepatology 2013; 7(4) doi: 10.1586/egh.13.21
47
Rubén Peña-Vélez, Enory Almanza-Miranda. Hepatitis autoinmune en la edad pediátrica. Boletín Médico del Hospital Infantil de México 2017; 74(5) doi: 10.1016/j.bmhimx.2017.05.004
48
Albert J Czaja. Safety issues in the management of autoimmune hepatitis. Expert Opinion on Drug Safety 2008; 7(3) doi: 10.1517/14740338.7.3.319
49
Simon Pape, Frederik Nevens, Chris Verslype, Caroline Mertens, Joost P.H. Drenth, Eric T.T.L. Tjwa. Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience. European Journal of Gastroenterology & Hepatology 2020; 32(6) doi: 10.1097/MEG.0000000000001580
50
Richard Parker, Ye Htun Oo, David H. Adams. Management of patients with difficult autoimmune hepatitis. Therapeutic Advances in Gastroenterology 2012; 5(6) doi: 10.1177/1756283X12450251
51
Gideon M. Hirschfield, Nadya Al-Harthi, E. Jenny Heathcote. Review: Current status of therapy in autoimmune liver disease. Therapeutic Advances in Gastroenterology 2009; 2(1) doi: 10.1177/1756283X08098966
52
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012; 36(6) doi: 10.1111/j.1365-2036.2012.05223.x
53
EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015; 63(4) doi: 10.1016/j.jhep.2015.06.030
54
Joanna Vitfell‐Pedersen, Marianne Hørby Jørgensen, Klaus Müller, Carsten Heilmann. Autoimmune Hepatitis in Children in Eastern Denmark. Journal of Pediatric Gastroenterology and Nutrition 2012; 55(4) doi: 10.1097/MPG.0b013e3182602b20
55
Neeraj Kumar Fuloria, Shivkanya Fuloria, Mahendran Sekar, Omji Porwal, Mohammed Tahir Ansari, Anupam Biswas, Kamal Narain, Sangita Biswas, Sumita Bhatia, Mogana Das Murtey. Regenerative Engineering of Fibrotic Diseases: Mechanistic and Clinical Advances with Bone Marrow Mesenchymal Stem Cells. Regenerative Engineering and Translational Medicine 2025;  doi: 10.1007/s40883-025-00509-7
56
Qixia Wang, Fan Yang, Qi Miao, Edward L. Krawitt, M. Eric Gershwin, Xiong Ma. The clinical phenotypes of autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2016; 66 doi: 10.1016/j.jaut.2015.10.006
57
Ashnila Janmohamed, Gideon M Hirschfield. Autoimmune hepatitis and complexities in management. Frontline Gastroenterology 2019; 10(1) doi: 10.1136/flgastro-2018-101015
58
Albert J Czaja. Current and future treatments of autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 2009; 3(3) doi: 10.1586/egh.09.15
59
Nicole MF van Gerven, Ynto S de Boer, Chris JJ Mulder, Carin MJ van Nieuwkerk, Gerd Bouma. Auto immune hepatitis. World Journal of Gastroenterology 2016; 22(19): 4651-4661 doi: 10.3748/wjg.v22.i19.4651
60
Edward L Krawitt. Clinical features and management of autoimmune hepatitis. World Journal of Gastroenterology 2008; 14(21): 3301-3305 doi: 10.3748/wjg.14.3301
61
Shiv Kumar Sarin, Ashok Choudhury. Management of acute-on-chronic liver failure: an algorithmic approach. Hepatology International 2018; 12(5) doi: 10.1007/s12072-018-9887-5
62
V. Selvarajah, A. J. Montano‐Loza, A. J. Czaja. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Alimentary Pharmacology & Therapeutics 2012; 36(8) doi: 10.1111/apt.12042
63
Cumali Efe, Hannes Hagström, Henriette Ytting, Rahima A. Bhanji, Niklas F. Müller, Qixia Wang, Tugrul Purnak, Luigi Muratori, Mårten Werner, Hanns-Ulrich Marschall, Paolo Muratori, Fulya Gunşar, Daniel Klintman, Albert Parés, Alexandra Heurgué–Berlot, Thomas D. Schiano, Mustafa Cengiz, Michele May-Sien Tana, Xiong Ma, Aldo J. Montano-Loza, Thomas Berg, Sumita Verma, Fin Stolze Larsen, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida, Staffan Wahlin. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2017; 15(12) doi: 10.1016/j.cgh.2017.06.001
64
A. J. Czaja. Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2014; 39(4) doi: 10.1111/apt.12592
65
Dermot Gleeson, Michael A Heneghan. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut 2011; 60(12) doi: 10.1136/gut.2010.235259
66
Henriette Ytting, Fin Stolze Larsen. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use. Scandinavian Journal of Gastroenterology 2015; 50(8) doi: 10.3109/00365521.2014.998271
67
Lars Bossen, Alessio Gerussi, Vasiliki Lygoura, George F. Mells, Marco Carbone, Pietro Invernizzi. Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews 2018; 17(9) doi: 10.1016/j.autrev.2018.02.013
68
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_26
69
Ignasi Olivas, Sergio Rodriguez-Tajes, Maria Carlota Londoño. Autoimmune hepatitis: Challenges and novelties. Medicina Clínica (English Edition) 2022; 159(6) doi: 10.1016/j.medcle.2022.08.008
70
A. J. Czaja. Review article: the management of autoimmune hepatitis beyond consensus guidelines. Alimentary Pharmacology & Therapeutics 2013; 38(4) doi: 10.1111/apt.12381
71
Mussarat N. Rahim, Rodrigo Liberal, Rosa Miquel, Nigel D. Heaton, Michael A. Heneghan. Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?. Liver Transplantation 2019; 25(6) doi: 10.1002/lt.25451
72
Anna E. C. Stoelinga, Maarten E. Tushuizen, Wilbert B. van den Hout, Mar D. M. Rodriguez Girondo, Elsemieke S. de Vries, Amar D. Levens, Dirk-Jan A. R. Moes, Tom J. G. Gevers, Suzanne van der Meer, Hans T. Brouwer, Hendrik J. M. de Jonge, Ynte S. de Boer, Ulrich H. W. Beuers, Adriaan J. van der Meer, Aad P. van den Berg, Maureen M. J. Guichelaar, Joost P. H. Drenth, Bart van Hoek, Sjoerd F. Bakker, JM Vrolijk, Patrick van der Veek, Nicole F. van Gerven. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial. Trials 2024; 25(1) doi: 10.1186/s13063-023-07832-w
73
Sina Hübener, Ye Htun Oo, Nwe Ni Than, Peter Hübener, Christina Weiler-Normann, Ansgar W. Lohse, Christoph Schramm. Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance. Clinical Gastroenterology and Hepatology 2016; 14(3) doi: 10.1016/j.cgh.2015.09.037
74
Elizabeth Mileti, Marion Peters. Autoimmune Hepatitis. 2012;  doi: 10.1007/978-1-60761-569-9_8
75
Loris Riccardo Lopetuso, Giammarco Mocci, Manuela Marzo, Francesca D’Aversa, Gian Lodovico Rapaccini, Luisa Guidi, Alessandro Armuzzi, Antonio Gasbarrini, Alfredo Papa. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver. International Journal of Molecular Sciences 2018; 19(8) doi: 10.3390/ijms19082199
76
Albert J. Czaja. Liver Disorders. 2017;  doi: 10.1007/978-3-319-30103-7_15
77
Albert J Czaja. Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2014; 15(12) doi: 10.1517/14656566.2014.931938
78
Dhruv Lowe, Savio John. Autoimmune hepatitis: Appraisal of current treatment guidelines. World Journal of Hepatology 2018; 10(12): 911-923 doi: 10.4254/wjh.v10.i12.911
79
Mohammadreza Abdollahi, Neda Khalilian Ekrami, Morteza Ghojazadeh, H Marike Boezen, Mohammadhossein Somi, Behrooz Z Alizadeh. Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?. World Journal of Gastroenterology 2020; 26(38): 5896-5910 doi: 10.3748/wjg.v26.i38.5896
80
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg. Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies. Journal of Immunology Research 2019; 2019 doi: 10.1155/2019/9437043
81
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 2017; 23(33): 6030-6048 doi: 10.3748/wjg.v23.i33.6030
82
Iliana Doycheva, Kymberly D. Watt, Aliya F. Gulamhusein. Autoimmune hepatitis: Current and future therapeutic options. Liver International 2019; 39(6) doi: 10.1111/liv.14062
83
Christina Weiler-Normann, Christoph Schramm, Alexander Quaas, Christiane Wiegard, Claudia Glaubke, Nadine Pannicke, Sina Möller, Ansgar W. Lohse. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. Journal of Hepatology 2013; 58(3) doi: 10.1016/j.jhep.2012.11.010
84
Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 2021; 53(11) doi: 10.1016/j.dld.2021.05.033
85
Lovkesh Anand, Ashok Choudhury, Chhagan Bihari, Barjesh C. Sharma, Manoj Kumar, Rakhi Maiwall, Soek Siam Tan, Samir R. Shah, Saeed Hamid, Amna S. Butt, Wasim Jafri, Yogesh K. Chawla, Sunil Taneja, Ajay Duseja, Radha K. Dhiman, Mamun Al Mahtab, Hasmik Ghazinyan, Zhongping Duan, Yu Chen, Akash Shukla, Jinhua Hu, Zaigham Abbas, Sombat Treeprasertsuk, Laurentius A. Lesmana, Cosmas R Lesmana, Jose D. Sollano, Gian Carpio, Manoj K. Sahu, Guresh Kumar, Shiv K. Sarin. Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy. Hepatology 2019; 70(2) doi: 10.1002/hep.30205
86
Pinelopi Arvaniti, Ignasi Olivas, Sergio Rodriguez-Tajes, George N. Dalekos, Maria-Carlota Londoño. Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?. Exploration of Digestive Diseases 2024;  doi: 10.37349/edd.2024.00042
87
Ellina Lytvyak, Gideon Hirschfield, Devika Shreekumar, Yu Jun Wong, Aldo J. Montano‐Loza. Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases. Liver International 2025; 45(8) doi: 10.1111/liv.70190
88
Alejandro Costaguta, Guillermo Costaguta, Fernando Álvarez. Autoimmune hepatitis: Towards a personalized treatment. World Journal of Hepatology 2024; 16(11): 1225-1242 doi: 10.4254/wjh.v16.i11.1225
89
Fahd Almalki, Sarah T. Alarmati, Razan N. Shata, Lama K. Almatrfi, Salma A. Binmahfoodh, Hana T. Alomayri, Ghida’a S. Qurban, Juri A. Alzahrani, Lamar J. Maddawi, Shatha M. Alharbi, Raghad F. Bahakeem, Rawan S. Azooni, Hassan Alwafi, Widya Normma Insani. Comparative Effectiveness of Mycophenolate Mofetil and Tacrolimus as a Second-Line Therapy for Autoimmune Hepatitis: A Systematic Review and Meta-Analysis. Medical Principles and Practice 2025; 35(3) doi: 10.1159/000548894
90
Yooyun Chung, Mussarat N Rahim, Jonathon J Graham, Yoh Zen, Michael A Heneghan. An update on the pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2021; 22(11) doi: 10.1080/14656566.2021.1895747
91
Hemant Chatrath, Larissa Allen, Thomas D. Boyer. Use of Sirolimus in the Treatment of Refractory Autoimmune Hepatitis. The American Journal of Medicine 2014; 127(11) doi: 10.1016/j.amjmed.2014.06.016
92
Keaton R. Jones, Craig S. Lammert. Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies. Current Hepatology Reports 2018; 17(3) doi: 10.1007/s11901-018-0401-2
93
John M. Vierling. Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clinical Gastroenterology and Hepatology 2015; 13(12) doi: 10.1016/j.cgh.2015.08.012
94
Georgios Giannakopoulos, Hans Verbaan, Inga-Lill Friis-Liby, Per Sangfelt, Nils Nyhlin, Sven Almer. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine. Digestive and Liver Disease 2019; 51(2) doi: 10.1016/j.dld.2018.10.004
95
Ansgar W. Lohse, Christina Weiler-Normann. Zakim and Boyer's Hepatology. 2018;  doi: 10.1016/B978-0-323-37591-7.00041-0
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.